Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline
2020 · Clinical Infectious Diseases · 739 citations
https://doi.org/10.1093/cid/ciaa1125
L
Lorenzo Guglielmetti
Inserm(FR)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
132
Papers
6.4K
Citations
31
h-index
61
i10-index
Lorenzo Guglielmetti is an academic researcher from Inserm. The author has contributed to research in topics: Tuberculosis Research and Epidemiology & Mycobacterium research and diagnosis & Pneumocystis jirovecii pneumonia detection and treatment. The author has an h-index of 31, co-authored 113 publications.
ORCID: 0000-0003-0886-9635Papers by this author
worksDrug-associated adverse events in the treatment of multidrug-resistant tuberculosis: an individual patient data meta-analysis
2020 · The Lancet Respiratory Medicine · 260 citations
https://doi.org/10.1016/s2213-2600(20)30047-3
Drug-associated adverse events in the treatment of multidrug-resistant tuberculosis: an individual patient data meta-analysis
2020 · The Lancet Respiratory Medicine · 260 citations
https://doi.org/10.1016/s2213-2600(20)30047-3
Treatment outcome definitions in nontuberculous mycobacterial pulmonary disease: an NTM-NET consensus statement
2018 · European Respiratory Journal · 253 citations
https://doi.org/10.1183/13993003.00170-2018
Rapid emergence of<i>Mycobacterium tuberculosis</i>bedaquiline resistance: lessons to avoid repeating past errors
2016 · European Respiratory Journal · 95 citations
https://doi.org/10.1183/13993003.01719-2016
Management of patients with multidrug-resistant tuberculosis
2019 · The International Journal of Tuberculosis and Lung Disease · 83 citations
https://doi.org/10.5588/ijtld.18.0622
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat